Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best S&P 500 Dividend Stocks to Buy in 2026. On January 20, TD Cowen ...

If you are wondering whether Merck's current share price reflects its true worth, this article walks through what the numbers ...

On December 12, Morgan Stanley lifted its price target on Merck & Co., Inc. (NYSE:MRK) to $102 from $100. The firm kept an Equal Weight rating on the stock. In its 2026 outlook for the biopharma space ...

Merck (MRK) closed the most recent trading day at $106.45, moving +1.13% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.19%. At the same time, the ...

Merck (MRK) ended the recent trading session at $111.01, demonstrating a +2.54% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.53%.

Forbes contributors publish independent expert analyses and insights. As a brief background, Merck develops pharmaceutical products for human health across various therapeutic areas and also creates ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options begin trading today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK options ...

The healthcare bellwether’s performance has been solid, with the company exceeding earnings expectations in each of the trailing four quarters. It delivered a four-quarter earnings surprise of 3.92%, ...

Merck & Co., Inc. (NYSE:MRK) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported that Merck & Co., ...

Merck (MRK) has recommended its shareholders refuse an unsolicited “mini-tender” offer by Tutanota LLC, noting that those who accept the bids may end up selling their shares at a discount to the ...